Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

HHMI researchers solve a longstanding mystery about the origin of new cells in the liver. Howard Hughes Medical Institute (HHMI) scientists have identified stem cells in the liver that give rise to ...

Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

In addition to the previous therapy with interferon-alpha, Hepcludex has recently become available as a drug that can effectively prevent HDV from entering liver cells. However, Hepcludex has no ...

Thai-Yen Ling at National Taiwan University underscores the potential of small extracellular vesicle (sEV) therapy and enhances the precision of acute liver failure treatment through the ...

Non-alcoholic fatty liver disease: Sugar breaks down into glucose which is used by cells for energy. Excess sugar or glucose gets converted into fat and get stored in liver but over the time, liver ...

They used “a very elegant surgical technique, which allows the insertion of a (relatively small) xeno-liver with limited disruption to the anatomy of ... “T-cell activity was inhibited by ...

stimulates liver cells to release glucose into the blood Antibodies Part of the immune system. They are produced by white blood cells and can bind to specific bacteria and viruses to label them ...